Jonathan Rothbard

Jonathan B. Rothbard was the founder of Amylin Pharmaceuticals, Inc. (1989), ImmuLogic Pharmaceutical Corp.
(1989), Cellgate, Inc. (1998), and Katexco Pharmaceuticals Corp.
(2018) with titles including Chief Scientific Officer-Palo Alto at ImmuLogic Pharmaceutical Corp.
and Chief Scientific Officer at Cellgate, Inc., and Chief Executive Officer, Director & CSO at Katexco Pharmaceuticals Corp.
Dr. Rothbard is also the founder of ETHZilla Corp.
Dr. Rothbard is currently the Director, Chief Executive & Scientific Officer at CannBioRex Pharmaceuticals Corp.
Former positions include Head-Molecular Immunology Laboratory at Imperial Cancer Research Fund Trading Ltd. and Chief Scientific Officer at KBL Merger Corp.
IV.
Education includes a doctorate from The Trustees of Columbia University in The City of New York (1977) and an undergraduate degree from Hamilton College (New York) (1973).